MW
Mats Wahlstrom bought $112K of TLSI stock
Mats Wahlstrom, Dir of TriSalus Life Sciences, Inc. (TLSI), bought 50,000 shares of TLSI stock worth $112K, per an SEC Form 4 filed Nov 16, 2026.
It was an open-market purchase.
The trade happened on Nov 12, 2026, 4 days before it was made public.
TLSI has moved -7.9% since the trade date, from $2.52 to $2.32 (Nov 20, 2026 close).
- Traded
- Nov 12, 2026
- Disclosed
- Nov 16, 2026
- Filing delay
- 4 days
- Price since
- -7.9%
- Role
- Dir
- Source
- SEC Form 4